Live Breaking News & Updates on தேசிய ப்ரிஸ்க்ரிப்ஶந் தணிக்கை

Stay updated with breaking news from தேசிய ப்ரிஸ்க்ரிப்ஶந் தணிக்கை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ACC: Analyses Find SGLT2i Therapy Effective But Underutilized


May 19, 2021
Current guidelines strongly recommend use of the therapy for cardiology, diabetes patients
In a series of presentations at ACC.21, the virtual meeting of the American College of Cardiology, researchers delivered data to confirm two observations about cardiovascular outcomes in heart failure patients with or without type 2 diabetes (T2D) and/or chronic kidney disease (CDK). First, the use of SGLT2 inhibitors is associated with reduced risk of cardiovascular death, worsening heart failure, and/or hospitalization for heart failure, and second, SGLT2i agents are woefully underused.
In a presentation titled, “Just Go With the Flo(zin): SGLT2i Should Be Added to A Few, Some, Most, All HFrEF Patients?”, Glenn Herrington, PharmD, Ambulatory Care Cardiology Pharmacist at New Hanover Regional Medical Center in Wilmington, North Carolina, reviewed findings from EMPA-REG OUTCOME, CANVAS PROGRAM,DECLARE-TIMI 58, VERTIS CV, DAPA-HF, and EMPEROR-REDUCED to assess b ....

United States , North Carolina , South Korea , Michaelj Blaha , Glenn Herrington , Rishav Adhikai , Peggy Peck , Boehringer Ingelheim Eli Lilly , Wayne Huey Herng Sheu , American Heart Association , American College Of Cardiology , American Diabetes Association , Johns Hopkins University School Of Medicine , National Prescription Audit , Aetna Foundation , Company Diabetes Alliance , Amgen Foundation , Novo Nordisk , American College , Should Be Added , Ambulatory Care Cardiology Pharmacist , New Hanover Regional Medical Center , Hopkins University School , Hopkins Associate Professor , Endocrinology Michael , Prescription Audit ,

News Scan for Dec 22, 2020


A study in
JAMA Internal Medicine today demonstrates a sharp decline in US hospital COVID-19 mortality rates during the first 6 months of the pandemic, with wide variation across hospitals and poorer outcomes linked to higher county-level case rates.  
Researchers compared outcomes for 38,517 adult COVID-19 patients admitted to 955 US hospitals during an early (Jan 1 to Apr 30) and late (from May 1 to Jun 30) pandemic period. They estimated each hospital s risk-standardized event rate (RSER), which is a measure of average patient risk of 30-day in-hospital mortality or referral to hospice.
The overall mean RSER for 955 hospitals was 11.8%, with a range from 9.1% to 15.7% for the best- and worst-performing hospital quintiles (absolute difference 6.59 percentage points; 95% confidence interval [CI], 6.4% to 6.8%; ....

Democratic Republic Of The Congo , United States , Ridgeback Biotherapeutics , Ebanga Ansuvimab Zykl , Us Biomedical Advanced Research , Drug Administration , Development Authority , University Of Michigan , Forum Infectious Diseases , National Prescription Audit , University Of Pittsburgh , Forum Infect Disabstract , Mott Poll , Gary Freed , Open Forum Infectious Diseases , Health Care System , Prescription Audit , Forum Infect , Democratic Republic , Advanced Research , ஜனநாயக குடியரசு ஆஃப் தி காங்கோ , ஒன்றுபட்டது மாநிலங்களில் , வளர்ச்சி அதிகாரம் , பல்கலைக்கழகம் ஆஃப் மிச்சிகன் , மன்றம் தொற்று நோய்கள் , தேசிய ப்ரிஸ்க்ரிப்ஶந் தணிக்கை ,